Fortrea Holdings (MEX:FTRE1) Beneish M-Score: -3.13 (As of Jun. 26, 2026)


MEX:FTRE1 Fortrea Holdings Inc MEX:FTRE1
66 GF Score
Price MXN435.30
GF Value MXN448.82
! 7 Warning Signs
View Full Analysis

What is Fortrea Holdings Beneish M-Score?

Fortrea Holdings MEX:FTRE1 66 Beneish M-Score is -3.13 as of Jun. 26, 2026. GuruFocus rates MEX:FTRE1 with a GF Score™ of 66/100 and a GF Value™ of MXN448.82. The stock has 7 warning signs investors should review. Among 831 Biotechnology companies, Fortrea Holdings ranks better than 78.34% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.13 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Fortrea Holdings's Beneish M-Score or its related term are showing as below:

MEX:FTRE1' s Beneish M-Score Range Over the Past 10 Years
Min: -3.53   Med: -3.22   Max: -2.65
Current: -3.13

During the past 6 years, the highest Beneish M-Score of Fortrea Holdings was -2.65. The lowest was -3.53. And the median was -3.22.


Fortrea Holdings Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Fortrea Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fortrea Holdings Beneish M-Score Chart

Fortrea Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial 0.00 0.00 -3.33 -3.53 -3.05

Fortrea Holdings Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.47 -2.65 -2.90 -3.05 -3.13

MEX:FTRE1 vs MAZE, KALV, BCAX: Beneish M-Score Comparison

For the Biotechnology subindustry, Fortrea Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fortrea Holdings Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fortrea Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Fortrea Holdings's Beneish M-Score falls into.


MEX:FTRE1
66GF Score
Fortrea Holdings Inc MEX:FTRE1
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fortrea Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Fortrea Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8047+0.528 * 1.0704+0.404 * 0.9563+0.892 * 0.931+0.115 * 1.0368
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.77+4.679 * -0.117456-0.327 * 1.1186
=-3.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was MXN11,173 Mil.
Revenue was 11477.814 + 11892.765 + 12864.787 + 13374.381 = MXN49,610 Mil.
Gross Profit was 2228.842 + 2360.547 + 2250.833 + 2513.698 = MXN9,354 Mil.
Total Current Assets was MXN15,896 Mil.
Total Assets was MXN48,389 Mil.
Property, Plant and Equipment(Net PPE) was MXN2,833 Mil.
Depreciation, Depletion and Amortization(DDA) was MXN1,433 Mil.
Selling, General, & Admin. Expense(SGA) was MXN7,976 Mil.
Total Current Liabilities was MXN16,754 Mil.
Long-Term Debt & Capital Lease Obligation was MXN19,805 Mil.
Net Income was -425.572 + -585.185 + -291.673 + -7059.067 = MXN-8,361 Mil.
Non Operating Income was 63.114 + -381.721 + -44.026 + -6336.026 = MXN-6,699 Mil.
Cash Flow from Operations was -306.556 + 2324.536 + 1592.277 + 410.477 = MXN4,021 Mil.
Total Receivables was MXN14,914 Mil.
Revenue was 13324.426 + 14536.423 + 13288.983 + 12135.236 = MXN53,285 Mil.
Gross Profit was 2383.38 + 2938.568 + 2920.071 + 2511.686 = MXN10,754 Mil.
Total Current Assets was MXN19,851 Mil.
Total Assets was MXN63,852 Mil.
Property, Plant and Equipment(Net PPE) was MXN3,073 Mil.
Depreciation, Depletion and Amortization(DDA) was MXN1,642 Mil.
Selling, General, & Admin. Expense(SGA) was MXN11,126 Mil.
Total Current Liabilities was MXN20,440 Mil.
Long-Term Debt & Capital Lease Obligation was MXN22,688 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(11173.061 / 49609.747) / (14914.028 / 53285.068)
=0.225219 / 0.279891
=0.8047

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(10753.705 / 53285.068) / (9353.92 / 49609.747)
=0.201815 / 0.18855
=1.0704

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (15895.825 + 2832.937) / 48388.947) / (1 - (19850.591 + 3072.822) / 63852.088)
=0.612954 / 0.640992
=0.9563

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=49609.747 / 53285.068
=0.931

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1642.218 / (1642.218 + 3072.822)) / (1433.155 / (1433.155 + 2832.937))
=0.348294 / 0.335941
=1.0368

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(7975.918 / 49609.747) / (11125.926 / 53285.068)
=0.160773 / 0.2088
=0.77

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((19805.314 + 16754.182) / 48388.947) / ((22688.144 + 20439.788) / 63852.088)
=0.755534 / 0.675435
=1.1186

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-8361.497 - -6698.659 - 4020.734) / 48388.947
=-0.117456

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Fortrea Holdings has a M-score of -3.25 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -3.13 mean?
Fortrea Holdings (MEX:FTRE1) has a Beneish M-Score of -3.13 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Fortrea Holdings and its competitors. According to the industry distribution chart, Fortrea Holdings ranks #180 out of 831 companies in the Biotechnology industry, placing it in the top 21.7%.
Is Fortrea Holdings' Beneish M-Score too high?
Fortrea Holdings' current Beneish M-Score is -3.13. Based on the distribution chart, Fortrea Holdings ranks #180 out of 831 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Fortrea Holdings has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does Fortrea Holdings' Beneish M-Score compare to MAZE and KALV?
According to the Biotechnology industry distribution chart, Fortrea Holdings ranks #180 out of 831 companies for Beneish M-Score. This places Fortrea Holdings in the top 22% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Fortrea Holdings and its competitors. Fortrea Holdings's current Beneish M-Score is -3.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fortrea Holdings stock overvalued right now?
Fortrea Holdings (MEX:FTRE1) has a current Beneish M-Score of -3.13. The stock's GF Value™ is MXN448.82, compared to a current price of MXN435.30 — trading 3% below its estimated fair value. The current Beneish M-Score is -3.13. Fortrea Holdings' overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Fortrea Holdings (MEX:FTRE1), the current Beneish M-Score is -3.13 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fortrea Holdings (MEX:FTRE1) Overvalued in 2026?

Based on GuruFocus' analysis, Fortrea Holdings stock appears to be undervalued. The current stock price of MXN435.30 is trading 3% below its estimated GF Value™ of MXN448.82.

Key valuation signals for MEX:FTRE1:

  • Beneish M-Score: -3.13
  • GF Value™: MXN448.82 vs. price of MXN435.30 (3% below fair value)
  • GF Score™: 66/100 with 7 warning signs

No single metric tells the full story. See the MEX:FTRE1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fortrea Holdings Business Description

Other Exchanges FTRE:USAK67:Germany
Address 8 Moore Drive, Durham, NC, USA, 27713
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
66GF Score

Get the complete analysis for MEX:FTRE1

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN435.30
Price
MXN448.82
GF Value